If you are a new applicant or existing grantee and have been impacted by COVID-19 or a natural disaster, please contact your Customer Service Manager or one of the agents at our Contact Centre to discuss your circumstances and how we can assist you.

You can find more information and support on our Emergency management page.

Biomedical Translation Bridge

The Biomedical Translation Bridge supports an organisation to fund and nurture early stage health and medical research ventures to reach proof-of-concept stage. With this support, we hope that the ventures have the potential to attract further capital and support. This opportunity is closed to new applications.


What do you get?

This grant provided up to $22.3 million across 4 years.

Who is this for?

Early stage health and medical research ventures were eligible to apply.


The intended outcomes of this grant opportunity were to:

  • de-risk and develop ventures so that they can attract further funding
  • nurture and mentor the next generation of health and medical research innovators in Australia
  • develop ventures to become attractive to the Biomedical Translation Fund

This opportunity aimed to assist in developing ventures that ultimately address health problems of national significance through disease :

  • prevention
  • cures 
  • treatments 

The grant provided $22.3 million over 4 years:

  • $10.4 million in 2018-19
  • $5.3 million in 2019-20
  • $5.3 million in 2020-21
  • $1.3 million in 2021-22

MTPConnect, an Industry Growth Centre, provides researchers with the opportunity to receive funding under Biomedical Translation Bridge and BioMedTech Horizons programs.

Need help?

  • Let us answer your question via phone, email or webchat. And if we can't help, we'll put you in touch with someone who can.

  • Monday – Friday, 8am – 8pm across Australia

Key documents

Grant opportunity guidelines